Baruch Samuel Blumberg

Baruch Samuel Blumberg (July 28, 1925 – April 5, 2011) was an American physician, geneticist, and co-recipient of the 1976 Nobel Prize in Physiology or Medicine for his discovery of the hepatitis B virus (HBV), and the development of diagnostic tests and the vaccine against it. His work has had a profound impact on public health, leading to significant reductions in hepatitis B-related diseases and deaths worldwide.

Early Life and Education

Baruch Samuel Blumberg was born in Brooklyn, New York, to a Jewish family. He attended Far Rockaway High School in Queens, New York. After high school, he enrolled at Union College in Schenectady, New York, where he earned his bachelor's degree in physics in 1946. Blumberg then pursued further studies at Columbia University, where he received his Master's degree in 1951. He was awarded a Ph.D. in biochemistry from the University of Oxford in 1957, where he was a member of Balliol College. Following his Ph.D., Blumberg earned his M.D. from the Columbia University College of Physicians and Surgeons in 1961.

Career and Research

Blumberg began his research career focusing on the diversity of human responses to infectious diseases and the role of genetics in these responses. His interest in genetics and biochemistry led him to explore the polymorphisms of blood proteins. In 1964, while working at the National Institutes of Health (NIH), Blumberg discovered an antigen in the blood of an Australian Aboriginal person, which he later identified as the surface antigen of the hepatitis B virus. This discovery was pivotal in understanding the transmission of hepatitis B and laid the groundwork for the development of diagnostic tests and the hepatitis B vaccine.

Blumberg's work extended beyond the laboratory. He was deeply involved in ethical and policy issues related to genetics and public health. He served as the Director of the NASA Astrobiology Institute from 1999 to 2002, where he worked on the potential for life on other planets and the implications for human health and disease.

Nobel Prize

In 1976, Baruch S. Blumberg was awarded the Nobel Prize in Physiology or Medicine along with D. Carleton Gajdusek for their "discoveries concerning new mechanisms for the origin and dissemination of infectious diseases." Blumberg's share of the prize was specifically for his discovery of the hepatitis B virus and its implications for disease prevention and control.

Legacy

Blumberg's discovery of the hepatitis B virus and his work on the vaccine have saved millions of lives worldwide. The hepatitis B vaccine, which was developed in the early 1980s, was the first cancer-preventing vaccine because chronic hepatitis B infection can lead to liver cancer. His work has also contributed to the understanding and prevention of other viral diseases.

Blumberg was a member of numerous scientific organizations and received several awards and honors in addition to the Nobel Prize, including the National Medal of Science in 1999.

Death

Baruch S. Blumberg passed away on April 5, 2011, at the age of 85. He was attending a conference on astrobiology in California at the time of his death. His legacy continues through the ongoing efforts to combat hepatitis B and through the scientific and ethical frameworks he helped establish in the fields of genetics and public health.

See Also

• Nobel Prize in Physiology or Medicine
• Hepatitis B virus
• Vaccine
• Genetics
• Biochemistry

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian